If the number of reported confirmed cases of #COVID19 continues to slow down, the 2% fatality rate people have been quoting will appear to rise. But it will be a statistical illusion. Let me explain why.... 1/
@shandro@ACEJointHealth In fact, some studies show fewer injection site reactions and "survivability". In other words, the biosimilar's efficacy lasts longer for some patients than the originator. These are things NOT being talked about that are important to patients like me.
Which Health Policies Actually Work? We Rarely Find Out: There’s surprisingly little rigorous research on programs like #Medicaid and #Medicare, by @afrakt https://t.co/eZAeejeaEP via @UpshotNYT